Cycle number | Completion rate in the eligible patients | Reasons for discontinuation of treatment (The number of patients) |
---|---|---|
1 | 97.7%(42/43) | Adverse event(1) |
2 | 93.0%(40/43) | Patient refusal(2) |
3 | 90.7%(39/43) | Adverse event(1) |
4 | 86.0%(37/43) | Patient refusal(2) |
5 | 74.4%(32/43) | Patient refusal(3) |
Adverse event(1) | ||
Recurrence(1) | ||
6 | 69.8%(30/43) | Patient refusal(1) |
Recurrence(1) | ||
7 | 69.8%(30/43) | |
8 | 69.8%(30/43) | |
9 | 62.8%(27/43) | Patient refusal(1) |
Recurrence(2) | ||
10 | 32.8%(27/43) | |
11 | 60.5%(26/43) | Recurrence(1) |
12 | 60.5%(26/43) | |
13 | 55.8%(24/43) | Adverse event(1) |
Recurrence(1) | ||
14 | 51.2%(22/43) | Adverse event(1) |
Recurrence(1) | ||
15 | 51.2%(22/43) | |
16 | 51.2%(22/43) | |
17 | 51.2%(22/43) | |
18 | 51.2%(22/43) |